C4 Therapeutics (CCCC) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $460000.0.
- C4 Therapeutics' Accumulated Depreciation & Amortization rose 407.24% to $460000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $460000.0, marking a year-over-year increase of 407.24%. This contributed to the annual value of $9.2 million for FY2024, which is 1897.46% up from last year.
- As of Q3 2025, C4 Therapeutics' Accumulated Depreciation & Amortization stood at $460000.0, which was up 407.24% from $615000.0 recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Accumulated Depreciation & Amortization registered a high of $9.2 million during Q4 2024, and its lowest value of $442000.0 during Q3 2024.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $6.8 million (2021), whereas its average is $4.9 million.
- Per our database at Business Quant, C4 Therapeutics' Accumulated Depreciation & Amortization crashed by 9477.92% in 2024 and then surged by 3727.68% in 2025.
- Quarter analysis of 5 years shows C4 Therapeutics' Accumulated Depreciation & Amortization stood at $6.9 million in 2021, then increased by 17.45% to $8.1 million in 2022, then dropped by 4.43% to $7.8 million in 2023, then increased by 18.97% to $9.2 million in 2024, then crashed by 95.02% to $460000.0 in 2025.
- Its last three reported values are $460000.0 in Q3 2025, $615000.0 for Q2 2025, and $456000.0 during Q1 2025.